Newborn Screening: Now and in the Future

[摘要] WHAT is the value of newborn screening (NBS) to the rare diseases community?This was the question posed to the audience by Nick Meade, of Genetic AllianceUK, at the session ‘Newborn Screening: Now and in the Future’ at the EuropeanCongress of Rare Diseases and Orphan Products on 14th May 2020. Given the wide rangeof credentials in the audience, with patient representative organisations making up 33% ofthose in attendance, followed by academics and industry representatives both at 14% andhealthcare professionals at 11%, it is clear that the value of NBS is acknowledged throughoutthe rare disease community.

[学科分类] 经济地理